Position in IBRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,864,842
+$1,603,489 QoQ
Shares Held
441,444
+49.7% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 403 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. IBRX ranks #136 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in IBRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,864,842 | 441,444 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,261,353 | 294,831 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $313,319 | 158,242 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $297,792 | 121,054 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $303,592 | 114,997 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $198,964 | 66,101 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $144,097 | 56,288 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $279,918 | 75,247 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $826,408 | 130,761 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $665,230 | 123,879 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $599,116 | 119,346 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $186,764 | 110,512 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $396,260 | 142,540 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $303,499 | 166,758 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $760,286 | 149,958 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $784,593 | 157,866 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $545,787 | 146,717 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $926,328 | 165,121 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,163,724 | 191,402 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,773,673 | 182,102 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,070,314 | 215,008 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,817,748 | 202,938 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||